Michael I Koukourakis Selected Research

Michael I Koukourakis Research Topics

Disease

111	Neoplasms (Cancer) 02/2024 - 01/2002
46	Hypoxia (Hypoxemia) 12/2023 - 08/2002
23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 01/2003
20	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2002
17	Adenocarcinoma 04/2024 - 07/2002
16	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 09/2004
15	Head and Neck Neoplasms (Head and Neck Cancer) 10/2023 - 08/2002
14	Carcinoma (Carcinomatosis) 06/2023 - 04/2002
13	Lung Neoplasms (Lung Cancer) 01/2023 - 06/2003
13	Neoplasm Metastasis (Metastasis) 05/2022 - 09/2003
9	Colorectal Neoplasms (Colorectal Cancer) 07/2011 - 05/2002
8	Endometrial Neoplasms (Endometrial Cancer) 01/2015 - 04/2002
6	Fever (Fevers) 06/2011 - 01/2002
6	Exanthema (Rash) 06/2011 - 01/2002
5	Lymphopenia (Lymphocytopenia) 04/2024 - 07/2002
5	Melanoma (Melanoma, Malignant) 10/2023 - 10/2003
5	Squamous Cell Carcinoma of Head and Neck 10/2023 - 02/2006
5	Necrosis 01/2022 - 09/2003
5	Urinary Bladder Neoplasms (Bladder Cancer) 08/2020 - 02/2007
4	Disease Progression 10/2023 - 08/2006
4	Rectal Neoplasms (Rectal Cancer) 05/2022 - 09/2008
4	Fibrosis (Cirrhosis) 06/2014 - 01/2007
3	Pneumonia (Pneumonitis) 07/2020 - 06/2009
3	Sarcoma (Soft Tissue Sarcoma) 02/2020 - 12/2003
3	Anemia 09/2019 - 05/2004
3	Neutropenia 09/2019 - 07/2002
3	Glioblastoma (Glioblastoma Multiforme) 08/2018 - 01/2014
3	Xerostomia 01/2018 - 11/2005
3	Carcinogenesis 02/2017 - 05/2004
3	B-Cell Lymphoma (Lymphoma, B Cell) 03/2013 - 11/2008
3	Proctitis 10/2012 - 09/2008
3	Ductal Carcinoma 06/2006 - 01/2003
3	Hypotension (Low Blood Pressure) 02/2006 - 08/2003
2	Laryngeal Neoplasms (Laryngeal Cancer) 01/2024 - 01/2021

Drug/Important Bio-Agent (IBA)

47	Proteins (Proteins, Gene)FDA Link 12/2023 - 08/2002
34	Amifostine (Ethyol)FDA LinkGeneric 01/2021 - 01/2002
29	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 04/2002
12	EnzymesIBA 01/2023 - 04/2002
11	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2023 - 08/2003
11	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2006
10	Lactate Dehydrogenase 5IBA 01/2016 - 01/2005
9	Oxygen (Dioxygen)IBA 01/2015 - 05/2004
8	Carbonic Anhydrase IXIBA 01/2020 - 09/2003
7	Docetaxel (Taxotere)FDA Link 08/2021 - 07/2002
7	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2006
7	ParaffinIBA 11/2020 - 01/2008
7	Thymidine PhosphorylaseIBA 11/2012 - 04/2002
6	liposomal doxorubicin (Doxil)FDA Link 01/2021 - 03/2005
6	Monoclonal AntibodiesIBA 08/2020 - 05/2002
6	IsoenzymesIBA 01/2019 - 08/2003
6	Transcription Factors (Transcription Factor)IBA 01/2017 - 10/2003
6	Lactic Acid (Lactate)FDA LinkGeneric 11/2012 - 01/2005
5	Biomarkers (Surrogate Marker)IBA 09/2023 - 08/2009
5	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2018 - 01/2005
5	Oxidoreductases (Dehydrogenase)IBA 10/2016 - 01/2005
4	Messenger RNA (mRNA)IBA 12/2023 - 02/2004
4	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 05/2004
4	Hormones (Hormone)IBA 01/2023 - 01/2006
4	LigandsIBA 04/2022 - 04/2013
4	Beclin-1IBA 12/2018 - 06/2011
4	Cathepsin DIBA 01/2018 - 01/2014
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2017 - 03/2006
4	Pyruvic Acid (Pyruvate)IBA 10/2016 - 01/2005
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2012 - 05/2006
4	Indicators and Reagents (Reagents)IBA 11/2011 - 02/2006
3	B7-H1 AntigenIBA 12/2023 - 10/2018
3	Cell-Free Nucleic AcidsIBA 09/2023 - 01/2023
3	AntigensIBA 01/2022 - 05/2004
3	Carbon DioxideIBA 01/2020 - 10/2006
3	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2020 - 02/2006
3	MicroRNAs (MicroRNA)IBA 10/2018 - 01/2015
3	PlatinumIBA 01/2018 - 12/2003
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2016 - 01/2006
3	Capecitabine (Xeloda)FDA Link 06/2011 - 09/2008
3	Bevacizumab (Avastin)FDA Link 06/2011 - 06/2007
3	Estrogens (Estrogen)FDA Link 09/2010 - 03/2006
3	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2007 - 04/2002
2	InterferonsIBA 02/2024 - 01/2023
2	Interferon Type IIBA 12/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2023
2	NivolumabIBA 10/2023 - 09/2022
2	Circulating Tumor DNAIBA 07/2023 - 01/2023
2	Perilipin-3IBA 01/2022 - 08/2021
2	apalutamideIBA 11/2021 - 01/2018
2	bicalutamide (Casodex)FDA LinkGeneric 11/2021 - 01/2018
2	Chloroquine (Aralen)FDA LinkGeneric 08/2021 - 11/2011
2	Aldehyde DehydrogenaseIBA 01/2021 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 07/2020
2	LipofuscinIBA 11/2020 - 02/2020
2	Programmed Cell Death 1 ReceptorIBA 08/2020 - 10/2018
2	Androgen Receptors (Androgen Receptor)IBA 11/2019 - 01/2018

Therapy/Procedure

78	Radiotherapy 10/2023 - 01/2002
29	Drug Therapy (Chemotherapy) 08/2021 - 01/2002
17	Therapeutics 07/2023 - 05/2002
11	Immunotherapy 10/2023 - 07/2019
9	Chemoradiotherapy 01/2024 - 08/2002
2	Re-Irradiation 10/2023 - 10/2023
2	Adjuvant Chemotherapy 05/2022 - 02/2004
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 05/2021 - 03/2005
2	Photochemotherapy (Photodynamic Therapy) 01/2021 - 06/2007